Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Completed · Phase 3
Conditions studied: Schizophrenia
In brief
The purpose of this study is to investigate the effects of flexibly dosed Brexpiprazole monotherapy in the improvement of early-episode schizophrenia through the assessment of social functioning, efficacy, and tolerability. Early-episode schizophrenia is defined as episodes occurring ≤ 5 years after the onset of the first episode.
Key facts
- Study ID
- NCT02013622
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- People needed
- 49
- Starts
- 2013-11-01
- Expected to finish
- 2014-10-01
- Last updated by the study team
- 2016-03-29
Who can join
Age: 18 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Cerritos, California, United States
- Study site — Chula Vista, California, United States
- Study site — Costa Mesa, California, United States
- Study site — Long Beach, California, United States
- Study site — Oakland, California, United States
- Study site — Oceanside, California, United States
- Study site — Pico Rivera, California, United States
- Study site — Riverside, California, United States
- Study site — San Diego, California, United States
- Study site — San Diego, California, United States
- Study site — Santa Ana, California, United States
- Study site — Torrance, California, United States
- Study site — Fort Lauderdale, Florida, United States
- Study site — Atlanta, Georgia, United States
- Study site — Hoffman Estates, Illinois, United States
- Study site — Lake Charles, Louisiana, United States
- Study site — Rochester, New York, United States
- Study site — Philadelphia, Pennsylvania, United States
- Study site — Memphis, Tennessee, United States
- Study site — Dallas, Texas, United States
- Study site — Dallas, Texas, United States
- Study site — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.